According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings (TTM) are -$11.66 M. an increase over its 2022 earnings that were of -$19.27 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$12.52 M | -35.05% |
2022 | -$19.27 M | 89.56% |
2021 | -$10.17 M | 662.18% |
2020 | -$1.34 M | -74.38% |
2019 | -$5.21 M | 39.3% |
2018 | -$3.74 M | -34.41% |
2017 | -$5.7 M | |
2015 | -$0.03 M | -60.32% |
2014 | -$0.06 M | -186.83% |
2013 | $0.06 M | -166.32% |
2012 | -$0.1 M | -59.2% |
2011 | -$0.24 M | |
2004 | -$0.14 M | -41.41% |
2003 | -$0.24 M | 102.65% |
2002 | -$0.12 M | -32.32% |
2001 | -$0.18 M |